Apposite Capital
Growth equityLondon · Growth–Late Stage · 22 people tracked
Investment thesis
Apposite Capital targets healthcare and life sciences SMEs across the UK and Europe, acting as first institutional capital to help them scale via growth and hybrid capital, management buyouts and buy-ins, retirement sales and founder transitions. It leverages deep sector expertise and a network of healthcare leaders to identify high-growth, high-impact opportunities. Its mission centers on enabling better healthcare for more people through three impact objectives: improving quality, increasing access, and promoting innovation. Value creation focuses on professionalising operations, recruiting talent, digital transformation, strengthening governance, and supporting buy-and-build strategies.
Source: firm website, verified Aug 3, 2026.
Team · 22 people
from the firm's website & curated
What they invest in
from 8 of 24 portfolio companiesHealthtech ×7Wellness & Fitness ×5Digital Health ×2Medical Devices ×2Mental Health ×2AI & Machine Learning ×1Cloud Computing ×1Cybersecurity ×1
HQs:United Kingdom×3Sweden×1United States×1
Investments · 24 tracked
founders shown can be your intro pathPharmaceutical & life sciences business (MBO)
Health & social care (foster care) business (Buyout)
Health & social care business (Founding & Growth)
Cloudflare provides a global cloud network platform delivering security, performance, and development services through sixty-plus integrated services including SASE, application security, and full-stack development infrastructure.
Cloud ComputingCybersecurityDeveloper ToolsSan Francisco, US
Matthew Prince(Founder)inDane Knechtin
Co-investorsCapitalGEQT VenturesFlagship PioneeringIcon VenturesKhosla VenturesLocalGlobe+14 more
Medtech & medical products company (MBO)
Emblation develops microwave-based medical devices and treatments for use in clinical care.
HardwareHealthtechMedical Devices
Health & social care business (MBO)
Medtech & medical products company (BIMBO)
Health & social care business (Replacement & Growth)
Lansen Omsorg operates LSS group homes (gruppbostäder) providing supported housing, a personal living coach, daily activities, and around-the-clock staffing for adults aged 18 and older with Asperger's, autism, autism-like conditions, or intellectual disabilities, including those with additional psychiatric needs.
HealthtechMental HealthWellness & Fitness
Health & social care business (MBO)
Mirada Medical develops medical imaging software that personalizes image-guided cancer therapy, supporting clinicians in cancer treatment planning.
AI & Machine LearningDigital HealthHealthtech
Pharmaceuticals & life sciences business (Replacement & Growth)
Health & social care business (MBO)
Riverdale Healthcare is a dental group operating practices across England that provides NHS, private, and specialist dental treatment.
HealthtechWellness & Fitness
Medtech & medical products company (MBO)
Health & social care business (Buy-in)
Swanton Care is a national provider of residential care and support services for children, young people, and adults with complex needs, including autism, learning disabilities, and mental health issues.
HealthtechMental HealthWellness & Fitness
Ultherapy is a non-invasive aesthetic treatment that uses micro-focused ultrasound energy with real-time imaging to lift and tighten skin by stimulating collagen and elastin production.
HealthtechMedical DevicesWellness & Fitness
Co-investorsNew Enterprise Associates (NEA)
Digital health company (Replacement & Growth)
Developed compact ultrasound systems using Zone Sonography imaging; acquired by Mindray.
Co-investorsInCube Ventures
Exits · 1
IPOs and acquisitions across the tracked portfolioZonareacq. by Mindray
Portfolio news
latest coverage across their companiesCloudflare Turnstile · marketbeat.com · Jul 18, 2026
Swanton Care · frpadvisory.com · Jan 22, 2026
Principals & officers · per Companies House
what is this? ⓘLLP designated member · since 2015
LLP designated member · since 2006
LLP member · since 2017
Rory Christian Robert Pope — significant influence or control limited liability partnership
Ford David Porter — 25–50% of voting rights, right to share surplus assets 25 to 50 percent limited liability partnership
Samuel James Caiger Gray — 25–50% of voting rights, right to share surplus assets 25 to 50 percent limited liability partnership
Frequently asked questions
- How many investments has Apposite Capital made?
- Apposite Capital has 24 tracked investments, 1 of which have exited via acquisition or IPO.
- What stage does Apposite Capital invest at?
- Apposite Capital invests at the Growth, Late Stage stages.
- What sectors does Apposite Capital focus on?
- Apposite Capital focuses on Biotech, Digital Health, Healthtech, Impact & Social Good, Medical Devices.
- Where is Apposite Capital located?
- Apposite Capital is headquartered in London, GB.
- Does Apposite Capital lead rounds?
- Yes, Apposite Capital leads investment rounds.
- Who does Apposite Capital co-invest with?
- Apposite Capital most often shares deals with New Enterprise Associates (NEA), EQT Ventures, Flagship Pioneering, among 15 tracked co-investors.
Images
Similar investors
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
Visionary Ventures is a venture capital fund investing from Series A through commercialization, leveraging partnerships with Key Opinion Leaders, industry experts, and strategic acquirers to source and vet deals.
Claret Capital Partners is a European venture debt provider that finances technology, life sciences and impact companies, having deployed over €1.5bn across more than 200 companies.